Year In Review: FDA Spotlights Social Media, But No Guidelines Yet
Executive Summary
As drug makers await feedback from FDA on the use of the Internet and newer technologies for drug promotion, more are warming to the idea that unbranded campaigns in these media are the safest bet, for now
You may also be interested in...
FDA Cites Imaging Drug Web Sites, Draws "Respectful" Disagreement
Bracco Diagnostics took down a promotional Web site in response to an untitled letter from DDMAC but disagrees that it hyped a study. GE Healthcare's Visipaque is cited in a separate letter.
The DTC Decade: A Marketing Trend And Its Political Consequences
The era of drug TV marketing may be waning. Ten years after FDA finalized its guidance on risk presentation in broadcast ads, spending on television advertising is down and Internet-based promotion is booming
The DTC Decade: A Marketing Trend And Its Political Consequences
The era of drug TV marketing may be waning. Ten years after FDA finalized its guidance on risk presentation in broadcast ads, spending on television advertising is down and Internet-based promotion is booming